Table 1.
Results of the counting and identification of yeast strains isolated from implanted devices in the ICU
| Patients | Sampling sites | Count and identification | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||
| Sex, age | ATB | T (°C)a | CVC | PVC | TP | UP | OBC | Swabb | Count (cells/mL) | Isolated strains |
| F, 18 | Gent + Ampi | 36.7 | X | <103 | C. glabrata | |||||
| M, 31 | Cefa + Cipr | 37.3 | X | <103 | C. glabrata | |||||
| M, 71 | Gent + Cipr | 38.1 | X | >103 | C. glabrata | |||||
| F, 64 | Gent + Cipr + Aclv | 37.1 | X | >103 | C. albicans | |||||
| X | – | C. albicans | ||||||||
| M, 23 | Gent + Cipr | 38.7 | X | >103 | C. glabrata | |||||
| X | <103 | C. glabrata | ||||||||
| F, 17 | – | 37.6 | X | <103 | C. glabrata | |||||
| F, 57 | Cefa + Oxa | 38.4 | X | <103 | C. glabrata | |||||
| M, 66 | Amp + Cefo | 37.3 | X | <103 | C. albicans | |||||
| F, 41 | Cefa + Oxa | 38.0 | X | >103 | C. glabrata | |||||
| F, 46 | – | 37.0 | X | >103 | C. glabrata | |||||
Notes:
a
Patient’s temperature at the time of sampling;
b
swabbing of the patient’s tongue.
Abbreviations: F, female; M, male; ATB, antibiotic therapy; Gent, gentamicin; Ampi, ampicillin; Cefa, cefazolin; Cipr, ciprofloxacin; Aclv, acyclovir; Oxa, oxacillin; Cefo, cefotaxime; CVC, central venous catheter; PVC, peripheral venous catheter; TP, tracheotomic probe; UP, urinary probe; OBC, orobronchial catheter; C. glabrata, Candida glabrata; C. albicans, Candida albicans.